Company & Sponsor Intelligence
University of Alabama, Tuscaloosa
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting1
Completed1
Countries1
Therapeutic footprint
alzheimersautismmigraine_headache
Indexed studies
NCT05820919Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT05581069Improving Outcomes in Autism: Community Implementation of Stepped Transition in Education Program
autism · United StatesNA
autism · United StatesNA
NCT05695885STEPS Implementation Trial
autism · United StatesNA
autism · United StatesNA
NCT01213056Mindfulness-Based Cognitive Therapy for the Treatment of Chronic Headache Pain
migraine_headache · United StatesPHASE1, PHASE2
migraine_headache · United StatesPHASE1, PHASE2
NCT04656860Juice Plus Supplement Clinical Trial
alzheimers · United StatesNA
alzheimers · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →